| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2012 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Church and Dwight | 43 | Q2 2024 | 5.1% |
| Johnson & Johnson | 43 | Q2 2024 | 3.9% |
| Apple Computer | 43 | Q2 2024 | 3.7% |
| Kimberly-Clark | 43 | Q2 2024 | 2.9% |
| Cisco Systems | 43 | Q2 2024 | 3.4% |
| Microsoft | 43 | Q2 2024 | 2.9% |
| Exxon Mobil | 43 | Q2 2024 | 2.9% |
| Pfizer | 43 | Q2 2024 | 2.3% |
| CSX Corp | 43 | Q2 2024 | 2.2% |
| Merck | 43 | Q2 2024 | 1.9% |
View New England Research & Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-07 |
| 13F-HR | 2024-07-09 |
| 13F-HR | 2024-04-16 |
| 13F-HR | 2024-02-06 |
| 13F-HR | 2023-10-10 |
| 13F-HR | 2023-07-05 |
| 13F-HR | 2023-04-06 |
| 13F-HR | 2023-01-09 |
| 13F-HR | 2022-10-06 |
| 13F-HR | 2022-07-20 |
View New England Research & Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.